
Company Info
Year Established2025
Contacts
Robyn Schlicher, Ph.D.Founder & CEO
Company Description
BeaconDx's proprietary MENSA technology isolates active antibody-secreting cells from a standard blood draw. By measuring the antibodies these cells produce in real-time, we provide a unique snapshot of the immune system, potentially identifying actionable treatment options
